Profile photo Frederieke van der Baan

Frederieke van der Baan

Assistant Professor

Strategic program(s):

Strategic program(s):

Contact

Recent publications

Validation of 11 added items of the outpatient version of the Utrecht Symptom Diary in patients receiving chemotherapy or targeted therapy Josephine J Koldenhof, Bernice O Akpobome, Danielle Zweers, Stance Klaasse, Saskia C C M Teunissen, Petronella O Witteveen, Karijn P M Suijkerbuijk, Alexander de Graeff, Frederieke H van der Baan
Journal of patient-reported outcomes, 2024, vol. 8
Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer Sietske C M W van Nassau, Guus M Bol, Frederieke H van der Baan, Jeanine M L Roodhart, Geraldine R Vink, Cornelis J A Punt, Anne M May, Miriam Koopman, Jeroen W G Derksen
Current treatment options in oncology, 2024, vol. 25, p.405-426
Benefit of adjuvant chemotherapy on recurrence free survival per consensus molecular subtype in stage III colon cancer Simone van de Weerd, Arezo Torang, Inge van den Berg, Veerle Lammers, Saskia van den Bergh, Nelleke Brouwer, Iris D. Nagtegaal, Miriam Koopman, Geraldine R. Vink, Frederieke H. van der Baan, Han van Krieken, Jan Koster, Jan N. Ijzermans, Jeanine M.L. Roodhart, Jan Paul Medema
International Journal of Cancer, 2024, vol. 156, p.456-466
Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months Ingrid A. Franken, Frederieke H. van der Baan, Geraldine R. Vink, Anne M. May, Wilhelmina M.U. van Grevenstein, Miriam Koopman, Jeanine M.L. Roodhart
European Journal of Cancer, 2024, vol. 208
Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases K. Zwart, M. N.G.J.A. Braat, F. H. van der Baan, A. M. May, J. M.L. Roodhart, D. Al-Toma, J. M.M.B. Otten, M. Los, T. Oostergo, R. J.A. Fijneman, J. M. van Dodewaard-de Jong, C. J.A. Punt, G. Meijer, J. J.W. Lagendijk, M. Koopman, M. Intven, G. M. Bol
Clinical and translational radiation oncology, 2024, vol. 49, p.1-5
Efficacy-effectiveness analysis on survival in a population-based real-world study of BRAF-mutated metastatic colorectal cancer patients treated with encorafenib-cetuximab Koen Zwart, Sietske C M W van Nassau, Frederieke H van der Baan, Miriam Koopman, Petur Snaebjornsson, Anna J van Gestel, Geraldine R Vink, Jeanine M L Roodhart
British Journal of Cancer, 2024, vol. 131, p.110-116